Your browser doesn't support javascript.
loading
Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study.
Baudry, Edwige; Naoun, Natacha; Auclin, Edouard; Saldana, Carolina; Barthelemy, Philippe; Geoffrois, Lionnel; Thibault, Constance; de Vries-Brilland, Manon; Borchiellini, Delphine; Maillet, Denis; Hirsch, Laure; Vauchier, Charles; Carril-Ajuria, Lucia; Colomba, Emeline; Bernard-Tessier, Alice; Escudier, Bernard; Flippot, Ronan; Albigès, Laurence.
Afiliación
  • Baudry E; Gustave Roussy, Department of Cancer Medicine, Université Paris-Saclay, Villejuif, France; Institut de Cancérologie de Lorraine, Department of Medical Oncology, Université de Lorraine, Nancy 54000, France.
  • Naoun N; Gustave Roussy, Department of Cancer Medicine, Université Paris-Saclay, Villejuif, France.
  • Auclin E; Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, AP-HP Centre, Department of Medical Oncology, Université Paris Cité, Paris 75015, France.
  • Saldana C; Hôpital Henri Mondor, AP-HP, Department of Medical Oncology, Université de Paris, Créteil 94000, France.
  • Barthelemy P; Institut de Cancérologie Strasbourg Europe, Department of Medical Oncology, Strasbourg 67200, France.
  • Geoffrois L; Institut de Cancérologie de Lorraine, Department of Medical Oncology, Université de Lorraine, Nancy 54000, France.
  • Thibault C; Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, AP-HP Centre, Department of Medical Oncology, Université Paris Cité, Paris 75015, France.
  • de Vries-Brilland M; Institut de Cancérologie de l'Ouest, Department of Medical Oncology, Université d'Angers, Angers 49055, France.
  • Borchiellini D; Centre Antoine-Lacassagne, Department of Medical Oncology, Université Côte d'Azur, Nice 06100, France.
  • Maillet D; Hôpital Lyon-Sud, Université de Lyon, Department of Medical Oncology, Pierre-Bénite 69495, France; Faculté de médecine Jacques Lisfranc, Saint Etienne 42270, France.
  • Hirsch L; Hôpital Cochin-Port Royal, Department of Medical Oncology, AP-HP, Paris 75014, France.
  • Vauchier C; Hôpital Bichat, AP-HP, Department of Thoracic Oncology, Université de Paris, Paris 75018, France.
  • Carril-Ajuria L; Gustave Roussy, Department of Cancer Medicine, Université Paris-Saclay, Villejuif, France; CHU Saint Pierre/CHU Brugmann, Brussels, Belgium.
  • Colomba E; Gustave Roussy, Department of Cancer Medicine, Université Paris-Saclay, Villejuif, France.
  • Bernard-Tessier A; Gustave Roussy, Department of Cancer Medicine, Université Paris-Saclay, Villejuif, France.
  • Escudier B; Gustave Roussy, Department of Cancer Medicine, Université Paris-Saclay, Villejuif, France.
  • Flippot R; Gustave Roussy, Department of Cancer Medicine, Université Paris-Saclay, Villejuif, France.
  • Albigès L; Gustave Roussy, Department of Cancer Medicine, Université Paris-Saclay, Villejuif, France. Electronic address: laurence.albiges@gustaveroussy.fr.
Eur J Cancer ; 193: 113292, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37717282
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Francia